In the types dimension, the market is partitioned into four methodological sub‑categories that define the technical backbone of molecular breeding. Marker‑assisted selection (MAS), still the most widely implemented technique, captures roughly 40 % of the market, driven by its established protocols and relatively low entry cost for conventional breeding programs. Genomic selection (GS), leveraging whole‑genome prediction models, commands about 30 % of spend as its predictive accuracy improves and computational costs decline. Gene‑editing technologies, principally CRISPR‑Cas platforms, occupy an emerging 20 % share, reflecting accelerated regulatory pathways and the ability to introduce precise allelic changes without linkage drag. Finally, speed breeding, which integrates controlled environment growth cycles with molecular screening, accounts for the remaining 10 % and is gaining traction in high‑value horticultural and specialty crops. The distribution across these types directly influences the market’s total valuation by allocating resources to equipment, software licences, and specialized consultancy services.